{"id":49753,"date":"2022-10-18T16:02:53","date_gmt":"2022-10-18T14:02:53","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/sotas-dental-imaging-software-gets-pearls-ai-pathology-detection-capabilities\/"},"modified":"2022-10-18T16:02:53","modified_gmt":"2022-10-18T14:02:53","slug":"sotas-dental-imaging-software-gets-pearls-ai-pathology-detection-capabilities","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/sotas-dental-imaging-software-gets-pearls-ai-pathology-detection-capabilities\/","title":{"rendered":"SOTA\u2019s Dental Imaging Software Gets Pearl\u2019s AI Pathology Detection Capabilities"},"content":{"rendered":"
\n

\nPearl and SOTA have partnered to offer native support for Pearl\u2019s industry-leading, FDA-cleared radiologic AI solution Second Opinion\u00ae within the <\/i>SOTA Cloud\u00ae software platform. SOTA Cloud\u00ae will be the first dental imaging software in the United States to offer a fully-integrated clinical AI feature set.<\/i>\n<\/p>\n

LOS ANGELES–(BUSINESS WIRE)–Pearl<\/a>, the global leader in dental AI solutions, and SOTA Imaging<\/a>, the leading manufacturer of dental imaging hardware and software, announced today a partnership to integrate Pearl\u2019s FDA-cleared Second Opinion\u00ae<\/a> real-time clinical pathology detection artificial intelligence (AI) solution with SOTA\u2019s popular SOTA Cloud<\/a>\u00ae dental imaging software. Native support for Pearl\u2019s chairside AI within SOTA\u2019s cloud-based imaging interface means that, for the first time, dentists in the United States can conveniently capture, display, and perform AI-assisted clinical evaluation of dental radiographs within a single software platform.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\n“Together with SOTA, we are pushing the envelope of dental imaging further toward a fully AI-powered dental future,\u201d said Ophir Tanz<\/a>, Pearl\u2019s founder and CEO. \u201cAI will be a basic utility in dentistry and we see obvious advantages to making that utility an integral feature of the tools that dentists are already using. Through this partnership, dentists using SOTA Cloud\u00ae can seamlessly access Pearl\u2019s AI capabilities to obtain better, more consistent insights from patient imagery and present cases to patients more effectively \u2013\u2013 leading to better outcomes, a higher standard of care and more productive patient communication.”\n<\/p>\n

\nPearl\u2019s Second Opinion\u00ae is a clinical AI system cleared for use as a patient-facing radiologic aid to dentists in over 90 countries. With native Second Opinion\u00ae integration, dental practices using SOTA Cloud\u00ae \u2013\u2013 the robust cloud-based dental imaging software which SOTA introduced last year to complement its line of state-of-the-art intraoral cameras and X-ray image sensors \u2013\u2013 can view automatic AI detections of most conditions commonly found in dental X-rays.\n<\/p>\n

\n\u201cUnderstanding the needs of clinicians and ensuring that dentists are able to focus solely on providing the best possible patient care has always been the top priority when developing our software,\u201d said SOTA founder and president Brian Kim. \u201cOur partnership with Pearl speaks directly to that focus by giving practices using SOTA Cloud\u00ae push-button access to the most innovative AI technology available for streamlined patient communication and improved image-based diagnostic evaluations.\u201d\n<\/p>\n

\nTo register for SOTA Cloud\u00ae with fully-integrated AI capabilities, visit: https:\/\/info.sotaimaging.com\/sotaxpearlpartnership<\/a>\n<\/p>\n

\nTo learn more about Pearl\u2019s Second Opinion\u00ae, visit: www.hellopearl.com\/products\/second-opinion<\/a>.\n<\/p>\n

\nTo learn more about SOTA Cloud\u00ae, visit: www.sotaimaging.com\/sota-cloud\/<\/a>\n<\/p>\n

\nAbout Pearl<\/b>\n<\/p>\n

\nPearl is shaping the future of dental care by delivering AI and computer vision solutions that advance efficiency, accuracy, transparency and patient care. Founded in 2019 by <\/b>Ophir Tanz, Pearl is backed by Craft Ventures and other leading venture capital firms. For more information or to request a demonstration, please visit https:\/\/www.hellopearl.com<\/a>.\n<\/p>\n

\nAbout SOTA<\/b>\n<\/p>\n

\nSOTA Imaging is a leading manufacturer of dental imaging hardware and software since 1987. SOTA Imaging solutions include Clio Prime & Clio Pedo digital x-ray sensors, the Claris i5HD intraoral camera, SOTA Image and SOTA Cloud dental imaging software, and aerosol reduction solutions, including the Cazoo Extraoral Aerosol Evacuator. Contact SOTA at (888) 266-7682, sales@sotaimaging.com<\/a>, or sotaimaging.com.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nErik Arvidson<\/b>
Matter Health for Pearl
\n
Pearl@matternow.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Pearl and SOTA have partnered to offer native support for Pearl\u2019s industry-leading, FDA-cleared radiologic AI solution Second Opinion\u00ae within the SOTA Cloud\u00ae software platform. SOTA Cloud\u00ae will be the first dental imaging software in the United States to offer a fully-integrated clinical AI feature set. LOS ANGELES–(BUSINESS WIRE)–Pearl, the global leader in dental AI solutions, … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49753","6":"format-standard","7":"category-industry"},"yoast_head":"\nSOTA\u2019s Dental Imaging Software Gets Pearl\u2019s AI Pathology Detection Capabilities - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/sotas-dental-imaging-software-gets-pearls-ai-pathology-detection-capabilities\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SOTA\u2019s Dental Imaging Software Gets Pearl\u2019s AI Pathology Detection Capabilities - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Pearl and SOTA have partnered to offer native support for Pearl\u2019s industry-leading, FDA-cleared radiologic AI solution Second Opinion\u00ae within the SOTA Cloud\u00ae software platform. SOTA Cloud\u00ae will be the first dental imaging software in the United States to offer a fully-integrated clinical AI feature set. LOS ANGELES–(BUSINESS WIRE)–Pearl, the global leader in dental AI solutions, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/sotas-dental-imaging-software-gets-pearls-ai-pathology-detection-capabilities\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-18T14:02:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221018005537\/en\/1605181\/21\/SOTA_Image.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sotas-dental-imaging-software-gets-pearls-ai-pathology-detection-capabilities\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sotas-dental-imaging-software-gets-pearls-ai-pathology-detection-capabilities\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"SOTA\u2019s Dental Imaging Software Gets Pearl\u2019s AI Pathology Detection Capabilities\",\"datePublished\":\"2022-10-18T14:02:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sotas-dental-imaging-software-gets-pearls-ai-pathology-detection-capabilities\\\/\"},\"wordCount\":555,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sotas-dental-imaging-software-gets-pearls-ai-pathology-detection-capabilities\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221018005537\\\/en\\\/1605181\\\/21\\\/SOTA_Image.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sotas-dental-imaging-software-gets-pearls-ai-pathology-detection-capabilities\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sotas-dental-imaging-software-gets-pearls-ai-pathology-detection-capabilities\\\/\",\"name\":\"SOTA\u2019s Dental Imaging Software Gets Pearl\u2019s AI Pathology Detection Capabilities - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sotas-dental-imaging-software-gets-pearls-ai-pathology-detection-capabilities\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sotas-dental-imaging-software-gets-pearls-ai-pathology-detection-capabilities\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221018005537\\\/en\\\/1605181\\\/21\\\/SOTA_Image.jpg\",\"datePublished\":\"2022-10-18T14:02:53+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sotas-dental-imaging-software-gets-pearls-ai-pathology-detection-capabilities\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sotas-dental-imaging-software-gets-pearls-ai-pathology-detection-capabilities\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sotas-dental-imaging-software-gets-pearls-ai-pathology-detection-capabilities\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221018005537\\\/en\\\/1605181\\\/21\\\/SOTA_Image.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221018005537\\\/en\\\/1605181\\\/21\\\/SOTA_Image.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sotas-dental-imaging-software-gets-pearls-ai-pathology-detection-capabilities\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SOTA\u2019s Dental Imaging Software Gets Pearl\u2019s AI Pathology Detection Capabilities\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SOTA\u2019s Dental Imaging Software Gets Pearl\u2019s AI Pathology Detection Capabilities - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/sotas-dental-imaging-software-gets-pearls-ai-pathology-detection-capabilities\/","og_locale":"en_US","og_type":"article","og_title":"SOTA\u2019s Dental Imaging Software Gets Pearl\u2019s AI Pathology Detection Capabilities - Pharma Trend","og_description":"Pearl and SOTA have partnered to offer native support for Pearl\u2019s industry-leading, FDA-cleared radiologic AI solution Second Opinion\u00ae within the SOTA Cloud\u00ae software platform. SOTA Cloud\u00ae will be the first dental imaging software in the United States to offer a fully-integrated clinical AI feature set. LOS ANGELES–(BUSINESS WIRE)–Pearl, the global leader in dental AI solutions, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/sotas-dental-imaging-software-gets-pearls-ai-pathology-detection-capabilities\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-18T14:02:53+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221018005537\/en\/1605181\/21\/SOTA_Image.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/sotas-dental-imaging-software-gets-pearls-ai-pathology-detection-capabilities\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/sotas-dental-imaging-software-gets-pearls-ai-pathology-detection-capabilities\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"SOTA\u2019s Dental Imaging Software Gets Pearl\u2019s AI Pathology Detection Capabilities","datePublished":"2022-10-18T14:02:53+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/sotas-dental-imaging-software-gets-pearls-ai-pathology-detection-capabilities\/"},"wordCount":555,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/sotas-dental-imaging-software-gets-pearls-ai-pathology-detection-capabilities\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221018005537\/en\/1605181\/21\/SOTA_Image.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/sotas-dental-imaging-software-gets-pearls-ai-pathology-detection-capabilities\/","url":"https:\/\/pharma-trend.com\/en\/sotas-dental-imaging-software-gets-pearls-ai-pathology-detection-capabilities\/","name":"SOTA\u2019s Dental Imaging Software Gets Pearl\u2019s AI Pathology Detection Capabilities - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/sotas-dental-imaging-software-gets-pearls-ai-pathology-detection-capabilities\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/sotas-dental-imaging-software-gets-pearls-ai-pathology-detection-capabilities\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221018005537\/en\/1605181\/21\/SOTA_Image.jpg","datePublished":"2022-10-18T14:02:53+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/sotas-dental-imaging-software-gets-pearls-ai-pathology-detection-capabilities\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/sotas-dental-imaging-software-gets-pearls-ai-pathology-detection-capabilities\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/sotas-dental-imaging-software-gets-pearls-ai-pathology-detection-capabilities\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221018005537\/en\/1605181\/21\/SOTA_Image.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221018005537\/en\/1605181\/21\/SOTA_Image.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/sotas-dental-imaging-software-gets-pearls-ai-pathology-detection-capabilities\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"SOTA\u2019s Dental Imaging Software Gets Pearl\u2019s AI Pathology Detection Capabilities"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49753","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49753"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49753\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49753"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49753"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49753"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}